News summary
[Haofan Biotech: There is no layout in the field of synthetic biology, and no cooperation in AI pharmaceuticals] Securities Times e Company News, Haifan Biotech (301393) stated on the interactive platform on May 17 that the company has no layout in the field of synthetic biology. There is no cooperation in AI pharmaceuticals. The company's main products are manyabugarciamax3...
Newsletter text
[Haofan Biotech: There is no layout in the field of synthetic biology, and no cooperation in AI pharmaceuticals] Securities Times e Company News, Haifan Biotech (301393) stated on the interactive platform on May 17 that the company has no layout in the field of synthetic biology. There is no cooperation in AI pharmaceuticals. The company's main products are peptide synthesis reagents, which can be widely used in amide bonds.abugarciamax3It has good commercial prospects in the research and development and production of small molecule chemical drugs and peptide drugs.